NYSE - Delayed Quote USD

IMAX Corporation (IMAX)

17.44 +0.29 (+1.69%)
At close: April 23 at 4:00 PM EDT
17.44 0.00 (0.00%)
After hours: April 23 at 6:06 PM EDT

Earnings Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 8888
Avg. Estimate 0.10.140.941.21
Low Estimate 0.010.080.720.93
High Estimate 0.150.211.191.48
Year Ago EPS 0.160.260.940.94

Revenue Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 10101010
Avg. Estimate 78.18M83.08M379.19M415.73M
Low Estimate 68.11M72.19M364.86M392.2M
High Estimate 82.65M92.24M397.27M428.82M
Year Ago Sales 86.95M97.98M374.84M379.19M
Sales Growth (year/est) -10.10%-15.20%1.20%9.60%

Earnings History

CURRENCY IN USD 3/31/2023 6/30/2023 9/30/2023 12/31/2023
EPS Est. 0.130.160.220.05
EPS Actual 0.160.260.350.17
Difference 0.030.10.130.12
Surprise % 23.10%62.50%59.10%240.00%

EPS Trend

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate 0.10.140.941.21
7 Days Ago 0.080.150.921.21
30 Days Ago 0.090.150.931.21
60 Days Ago 0.10.150.781.05
90 Days Ago 0.120.170.851.07

EPS Revisions

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days 1--1--
Up Last 30 Days 3--32
Down Last 7 Days --------
Down Last 30 Days --1--1

Growth Estimates

CURRENCY IN USD IMAXIndustrySectorS&P 500
Current Qtr. -37.50%----0.40%
Next Qtr. -46.20%----9.90%
Current Year 0.00%----4.30%
Next Year 28.70%----13.40%
Next 5 Years (per annum) 20.00%----11.09%
Past 5 Years (per annum) -2.30%------

Research Analysis

Analyst Price Targets

14.50 Low
22.06 Average
17.44 Current
25.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Upgrades & Downgrades

Maintains Barrington Research: Outperform to Outperform 4/22/2024
Reiterates Wedbush: Outperform to Outperform 4/18/2024
Reiterates Benchmark: Buy to Buy 4/16/2024
Reiterates Wedbush: Outperform to Outperform 4/10/2024
Reiterates Benchmark: Buy to Buy 4/10/2024
Reiterates Barrington Research: Outperform to Outperform 3/4/2024

Related Tickers